A Study to Evaluate the Safety and Efficacy of Raltegravir (MK0518) in HIV-Infected Patients Failing Current Antiretroviral Therapies (0518-019)
Clinical trial NCT00293254 · COMPLETED
Trial details
- NCT number
- NCT00293254
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-02-01
- Primary completion
- 2007-10-01
- Enrollment
- 351
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.